Illumina, Inc. is a global leader in DNA sequencing and array-based technologies used for genetic analysis in research, clinical, and applied markets. The company provides instruments, consumables, and informatics solutions that enable high-throughput sequencing and genomic data interpretation. Illumina’s platforms are widely used in oncology, reproductive health, population genomics, and other precision medicine applications.